Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;40(3): 305-307, Mar. 2007.
Artigo em Inglês | LILACS | ID: lil-441770

RESUMO

Disorders of the lipid metabolism may play a role in the genesis of abdominal aorta aneurysm. The present study examined the intravascular catabolism of chylomicrons, the lipoproteins that carry the dietary lipids absorbed by the intestine in the circulation in patients with abdominal aorta aneurysm. Thirteen male patients (72 ± 5 years) with abdominal aorta aneurysm with normal plasma lipid profile and 13 healthy male control subjects (73 ± 5 years) participated in the study. The method of chylomicron-like emulsions was used to evaluate this metabolism. The emulsion labeled with 14C-cholesteryl oleate and ³H-triolein was injected intravenously in both groups. Blood samples were taken at regular intervals over 60 min to determine the decay curves. The fractional clearance rate (FCR) of the radioactive labels was calculated by compartmental analysis. The FCR of the emulsion with ³H-triolein was smaller in the aortic aneurysm patients than in controls (0.025 ± 0.017 vs 0.039 ± 0.019 min-1; P < 0.05), but the FCR of14C-cholesteryl oleate of both groups did not differ. In conclusion, as indicated by the triglyceride FCR, chylomicron lipolysis is diminished in male patients with aortic aneurysm, whereas the remnant removal which is traced by the cholesteryl oleate FCR is not altered. The results suggest that defects in the chylomicron metabolism may represent a risk factor for development of abdominal aortic aneurysm.


Assuntos
Humanos , Masculino , Idoso , Aneurisma da Aorta Abdominal/metabolismo , Ésteres do Colesterol/farmacocinética , Quilomícrons/farmacologia , Lipólise , Trioleína/farmacocinética , Aneurisma da Aorta Abdominal/sangue , Índice de Massa Corporal , Radioisótopos de Carbono , Estudos de Casos e Controles , Ésteres do Colesterol/administração & dosagem , Quilomícrons/administração & dosagem , Emulsões , Injeções Intravenosas , Taxa de Depuração Metabólica , Trioleína/administração & dosagem
2.
Immunology ; 86(3): 399-407, 1995 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8550077

RESUMO

Natural killer (NK) cells take up chylomicrons (CM), very low density (VLDL), low density (LDL), high density (HDL) and acetyl-modified low density (AcLDL) lipoproteins through different receptors, VLDL being the lipoprotein with the highest uptake and HDL the lowest. The uptake of LDL can be selectively blocked by the anti-LDL receptor, which does not affect the uptake of CM, VLDL, HDL and AcLDL. Although the uptake of lipoproteins assessed by flow cytometry using DiI is not very high, the lipoproteins are able to induce an increase in proliferative responses, VLDL, AcLDL and HDL being the most important ones with 12- and 17-fold increments, respectively. CM, VLDL and LDL at low concentrations increase NK cytotoxic activity, while HDL and AcLDL inhibit, in a dose-dependent fashion, the killing of NK cells against K562. These results suggest the presence of four different receptors that are responsible for the cytotoxic and proliferative responses observed.


Assuntos
Células Matadoras Naturais/metabolismo , Receptores de Lipoproteínas/metabolismo , Acetilação , Células Cultivadas , Quilomícrons/metabolismo , Quilomícrons/farmacologia , Citotoxicidade Imunológica , Relação Dose-Resposta a Droga , Citometria de Fluxo , Humanos , Imunidade Celular , Células Matadoras Naturais/imunologia , Lipoproteínas HDL/metabolismo , Lipoproteínas HDL/farmacologia , Lipoproteínas LDL/metabolismo , Lipoproteínas LDL/farmacologia , Lipoproteínas VLDL/metabolismo , Lipoproteínas VLDL/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA